Pure Bioscience (PURE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0653 +0.0053 (+8.83%) 04/25/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0653 unch (unch) 12:49 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2024 | 07-2023 | 07-2022 | 07-2021 | 07-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,350 | -3,961 | -3,491 | -2,319 | 4 |
| Depreciation Amortization | 148 | 117 | 213 | 172 | 196 |
| Accounts receivable | 130 | -78 | 167 | 721 | -716 |
| Other Working Capital | 397 | -107 | 103 | -11 | -318 |
| Other Operating Activity | 144 | 751 | 590 | 270 | 1,503 |
| Operating Cash Flow | $-2,531 | $-3,278 | $-2,418 | $-1,167 | $669 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -33 | -81 | -521 | -58 |
| Investing Cash Flow | $N/A | $-33 | $-81 | $-521 | $-58 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,785 | 1,015 | N/A | 239 | N/A |
| Common Stock Issued | N/A | N/A | 3,500 | N/A | 2,830 |
| Financing Cash Flow | $1,785 | $1,015 | $3,500 | $239 | $2,830 |
| Beginning Cash Position | 1,170 | 3,466 | 2,465 | 3,914 | 473 |
| End Cash Position | 424 | 1,170 | 3,466 | 2,465 | 3,914 |
| Net Cash Flow | $-746 | $-2,296 | $1,001 | $-1,449 | $3,441 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,531 | -3,278 | -2,418 | -1,167 | 669 |
| Capital Expenditure | N/A | -33 | -81 | -521 | -58 |
| Free Cash Flow | -2,531 | -3,311 | -2,499 | -1,688 | 611 |